Fundraising Fox
Domain Therapeutics
Founded 2008 · 36 employees on LinkedIn · 11 known investors
Find your way into Domain Therapeutics
Sign up to see every warm intro you have to Domain Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Domain Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation. The company leverages a proprietary drug discovery platform and two decades of expertise to create first-in-class and best-in-class drug candidates.
Investors · 11
How we know: funding news · domaintherapeutics.com · Not right? Tell us
How we know: CTI Life Sciences Fund L.P.'s portfolio page · Not right? Tell us
How we know: funding news · domaintherapeutics.com · Not right? Tell us
How we know: funding news · domaintherapeutics.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountseries AMay 2022
3B Future Health Fund (lead), CTI Life Sciences (lead), Panacea Venture (lead), adMare BioInnovations, Omnes, Schroders Capital, Seventure Partners, Theodorus, Turenne Capital, Viva BioInnovator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Domain Therapeutics do?
- Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation. The company leverages a proprietary drug discovery platform and two decades of expertise to create first-in-class and best-in-class drug candidates.
- Who are Domain Therapeutics's investors?
- Domain Therapeutics's investors include 3B Future Health Fund, CTI Life Sciences Fund L.P., adMare BioInnovations, Omnes Capital, Panacea Venture, Seventure Partners.